Albendazol para la filariasis linfática
Información
- DOI:
- https://doi.org/10.1002/14651858.CD003753.pub3Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 19 octubre 2005see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Enfermedades infecciosas
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Julia Critchley assessed studies for inclusion, extracted data, and is responsible for preparing and updating the review. Paul Garner edited the review, extracted data, and assessed the risk of bias in the trials. David Addiss and Hellen Gelband edited the review. Carrol Gamble edited the review and provided statistical input. Henry Ejere assessed studies for inclusion and extracted data.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
Department for International Development, UK.
Declaraciones de interés
Para la primera versión de la revisión (IFRG 2004), el Lymphatic Filariasis Support Centre basado en la Liverpool School of Tropical Medicine financió el salario de Henry Ejere. El Departamento para el Desarrollo Internacional, Reino Unido y GlaxoSmithKline patrocinan al Lymphatic Filariasis Support Centre. El Dr. Addiss es autor de uno de los ensayos.
Julia Critchley, Paul Garner, Hellen Gelband, Carrol Gamble: ninguno conocido.
Agradecimientos
Se agradece a Leanne Fox y otros autores del trabajo Fox 2005 por proporcionar análisis adicionales de su ensayo. La primera versión de la revisión recibió el apoyo del Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, RU y GlaxoSmithKline, RU.
Este documento es resultado de un proyecto financiado por Department for International Development (DFID) del RU para el beneficio de los países en desarrollo. Los criterios expresados no son necesariamente los de DFID.
Version history
| Published | Title | Stage | Authors | Version |
| 2019 Jan 08 | Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis | Review | Cara L Macfarlane, Shyam S Budhathoki, Samuel Johnson, Marty Richardson, Paul Garner | |
| 2005 Oct 19 | Albendazole for lymphatic filariasis | Review | David Addiss, Carrol L Gamble, Paul Garner, Hellen Gelband, Henry OD Ejere, Julia A Critchley, International Filariasis Review Group | |
| 2004 Jan 26 | Albendazole for lymphatic filariasis | Review | A ddiss International Filariasis Review Group (David, C ritchley Julia, E jere Henry, G arner Paul, G elband Hellen, G amble) Carrol, Julia Critchley, Carrol Gamble, David Addiss, Henry OD Ejere, Hellen Gelband, Paul Garner | |
| 2002 Apr 22 | Albendazole for lymphatic filariasis | Protocol | A ddiss International Filariasis Review Group (David, E jere Henry, G arner Paul, G elband Hellen, P reston) Carrol, Henry OD Ejere, David Addiss, Hellen Gelband, Paul Garner | |
Differences between protocol and review
The first version of the review (IFRG 2004), published in Issue 1, 2004, deviated from the published protocol: Julia Critchley was invited to join the review team; the objectives were reworded; and the subgroups were removed from the review methods because they were no longer appropriate.
